Cost‐Effectiveness of Computer‐Assisted Cytology in a Primary hrHPV‐Based Cervical Cancer Screening Programme

Autor: Ellen M. G. Olthof, S. Kaljouw, Folkert J. vanKemenade, Anne M. Uyterlinde, Inge M. C. M. deKok

Publikováno v: Cancer Medicine, Vol 13, Iss 19, Pp n/a-n/a (2024)

ABSTRACT Background Computer‐assisted screening (CAS) shows equal performance compared to manual screening, although results are heterogeneous. Furthermore, using CAS may save costs through a potentially increased screening productivity of technici

Externí odkaz: https://doaj.org/article/0b2d968138c84c8986934c8064f22106

DNA hypermethylation analysis in sputum of asymptomatic subjects at risk for lung cancer participating in the NELSON trial: argument for maximum screening interval of 2years

Autor: Anne M. Uyterlinde, Clemens F.M. Prinsen, Harry J.M. Groen, Susanne E van der Meer, Anne S. Bolijn, Hans Berkhof, Harry J. de Koning, A. Jasmijn Hubers, Renske D.M. Steenbergen, Birgit I. Witte, Mandy Wouters, Daniëlle A.M. Heideman, Peter J.F. Snijders, Erik Thunnissen, Sylvia Duin, Egbert F. Smit

Publikováno v: Journal of Clinical Pathology, 70(3), 250-254. BMJ Publishing Group
Journal of Clinical Pathology, 70(3), 250-254. BMJ PUBLISHING GROUP
Journal of Clinical Pathology. BMJ Publishing Group
Hubers, A J, Heideman, D A M, Duin, S, Witte, B I, de Koning, H J, Groen, H J M, Prinsen, C F M, Bolijn, A S, Wouters, M, van der Meer, S E, Steenbergen, R D M, Snijders, P J F, Uyterlinde, A, Berkhof, H, Smit, E F & Thunnissen, E 2016, ' DNA hypermethylation analysis in sputum of asymptomatic subjects at risk for lung cancer participating in the NELSON trial : argument for maximum screening interval of 2 years ', Journal of Clinical Pathology . https://doi.org/10.1136/jclinpath-2016-203734

AIMS: Lung cancer is the major contributor to cancer mortality due to metastasised disease at time of presentation. The current study investigated DNA hypermethylation of biomarkers RASSF1A, APC, cytoglobin, 3OST2, FAM19A4, PHACTR3 and PRDM14 in sput

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7729a9a7bca4fb579443bbf94ae1e493
https://doi.org/10.1136/jclinpath-2016-203734

Human papillomavirus infection in Rwanda at the moment of implementation of a national HPV vaccination programme

Autor: Silvia Franceschi, Iacopo Baussano, Agnes Binagwaho, Peter J.F. Snijders, Vanessa Tenet, Fidele Ngabo, Anne M. Uyterlinde, Chantal M.C. Umulisa, Maurice Gatera, Fulvio Lazzarato, Gary M. Clifford

Publikováno v: BMC Infectious Diseases
BMC Infectious Diseases, 16. BioMed Central
BMC infectious diseases, 16 (1
Ngabo, F, Franceschi, S, Baussano, I, Umulisa, M C, Snijders, P J F, Uyterlinde, A M, Lazzarato, F, Tenet, V, Gatera, M, Binagwaho, A & Clifford, G M 2016, ' Human papillomavirus infection in Rwanda at the moment of implementation of a national HPV vaccination programme ', BMC Infectious Diseases, vol. 16 . https://doi.org/10.1186/s12879-016-1539-6

Background: Cervical cancer is the most common female cancer in Rwanda that, in 2011, became the first African country to implement a national vaccination programme against human papillomavirus (HPV). Methods: To provide a robust baseline for future

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::900cd86fc0854e2064c6f8ddf38bb255
https://pubmed.ncbi.nlm.nih.gov/27221238

Seroconversion for Helicobacter pylori

Autor: N. F. M. Pels, A. M. Uyterlinde, S.G.M. Meuwissen, Ernst J. Kuipers, Amado Salvador Peña, G. van Kamp, E. Kurz-Pohlmann, Gerard Pals

Publikováno v: The Lancet, 342(8867), 328-331. Elsevier Limited
Kuipers, E J, Peña, A S, Pels, N F M, Kurz-Pohlmann, E, Meuwissen, S G M, van Kamp, G, Uyterlinde, A M & Pals, G 1993, ' Seroconversion for Helicobacter pylori ', The Lancet, vol. 342, no. 8867, pp. 328-331 . https://doi.org/10.1016/0140-6736(93)91473-Y

The prevalence of Helicobacter pylori antibodies increases with age, but it is unknown whether this is due to a constant rate of infection in different age groups, or whether most infection occurs in childhood. Follow-up data on infection rates and t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e7851239500fb790a30378e06010499
http://www.scopus.com/inward/record.url?scp=0027182218&partnerID=8YFLogxK

The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 world health organization classification system

Autor: Feja J. Voorhorst, Curt W. Burger, Paul J. van Diest, A. M. Uyterlinde, René H.M. Verheijen, Bent Fiane, Juan Palazzo, Stanley Robboy, Anne Ørbo, George L. Mutter, Jan P. A. Baak, Kjell Løvslett

Publikováno v: Baak, J P, Mutter, G L, Robboy, S, Van Diest, P J, Uyterlinde, A M, Ørbo, A, Palazzo, J, Fiane, B, Løvslett, K, Burger, C, Voorhorst, F & Verheijen, R H 2005, ' The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 world health organization classification system ', Cancer, vol. 103, no. 11, pp. 2304-2312 . https://doi.org/10.1002/cncr.21058
Cancer, 103(11), 2304-2312. John Wiley and Sons Inc.

BACKGROUND. The objective of this study was to compare the accuracy of disease progression prediction of the molecular genetics and morphometry-based Endometrial Intraepithelial Neoplasia (EIN) and World Health Organization 1994 (WHO94) classificatio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d5fe87b544cc239c43a9e0dea28aa7b
https://research.vumc.nl/en/publications/77d5ee9a-4481-4916-9f4c-464267c86d70